Flunarizine hydro-chloride capsule pill
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ζε€§ιΉ
- Publication Date
- 2003-01-22
- Estimated Expiration
- Not applicable Β· inactive patent
Abstract
Description
technical field
[0001] The invention relates to the technical field of flunarizine hydrochloride capsule preparations. Background technique
[0002] Clinically, flunarizine hydrochloride is a drug for treating cerebrovascular diseases, such as treating cerebral insufficiency, vertebral artery ischemia, cerebral thrombosis and other cerebrovascular diseases. It has been clinically proven that flunarizine hydrochloride has a stronger expansion effect on cerebral blood vessels than on coronary arteries and mesenteric arteries. It can increase cerebral blood flow at a dose that does not cause a drop in systemic blood pressure, and it is currently the only calcium channel blocker. The only drug in the drug that can pass the blood-brain barrier. At present, the traditional preparations of this medicine are mostly capsules and tablets. Since the drug is very slightly soluble in water, and the production process of each manufacturer is different, it directly affects the dissolutio...